<SEC-DOCUMENT>0000899243-22-023587.txt : 20220622
<SEC-HEADER>0000899243-22-023587.hdr.sgml : 20220622
<ACCEPTANCE-DATETIME>20220622170012
ACCESSION NUMBER:		0000899243-22-023587
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220616
FILED AS OF DATE:		20220622
DATE AS OF CHANGE:		20220622

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Levy Guy
		CENTRAL INDEX KEY:			0001812305

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39787
		FILM NUMBER:		221032688

	MAIL ADDRESS:	
		STREET 1:		C/O SOLEUS PRIVATE EQUITY GP I, LLC
		STREET 2:		104 FIELD POINT ROAD, 2ND FLOOR
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioAtla, Inc.
		CENTRAL INDEX KEY:			0001826892
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				851922320
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		11085 TORREYANA ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-558-0708

	MAIL ADDRESS:	
		STREET 1:		11085 TORREYANA ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2022-06-16</periodOfReport>

    <notSubjectToSection16>1</notSubjectToSection16>

    <issuer>
        <issuerCik>0001826892</issuerCik>
        <issuerName>BioAtla, Inc.</issuerName>
        <issuerTradingSymbol>BCAB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001812305</rptOwnerCik>
            <rptOwnerName>Levy Guy</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O SOLEUS CAPITAL MANAGEMENT, L.P.</rptOwnerStreet1>
            <rptOwnerStreet2>104 FIELD POINT ROAD, 2ND FLOOR</rptOwnerStreet2>
            <rptOwnerCity>GREENWICH</rptOwnerCity>
            <rptOwnerState>CT</rptOwnerState>
            <rptOwnerZipCode>06830</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>1</isOther>
            <otherText>Former Director</otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <footnotes></footnotes>

    <remarks>Mr. Guy Levy resigned as a member of the Board of Directors of BioAtla, Inc. (the &quot;Issuer&quot;) effective June 16, 2022. As a result, Mr. Levy is no longer subject to Section 16 of the Securities Exchange Act of 1934, as amended, in connection with his transactions in the equity securities of the Issuer and therefore will no longer report any such transactions by him or by any of the entities with respect to which he directly or indirectly holds voting or dispositive control over the equity securities of the Issuer held by such entities, including, without limitation, Soleus Capital Master Fund, L.P., Soleus Private Equity Fund I, L.P. and Soleus BA SPV, LLC, on Form 4 or Form 5.</remarks>

    <ownerSignature>
        <signatureName>Guy Levy /s/ Guy Levy</signatureName>
        <signatureDate>2022-06-22</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
